←Back to Expert Scholars
Translational Medicine / 转化医学Chemoprevention, Breast Cancer
Bernardo Bonanni
MD
🏢European Institute of Oncology (IEO)🌐Italy
Director, Division of Cancer Prevention and Genetics
65
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Bernardo Bonanni led the TAM-01 trial demonstrating that low-dose tamoxifen (5 mg daily) reduced recurrence of breast intraepithelial neoplasia. He has shaped European breast cancer chemoprevention guidelines. He directs cancer prevention and genetics at IEO Milan.
Share:
🧪Research Fields 研究领域
tamoxifen prevention
low-dose tamoxifen TAM-01
DCIS prevention
aromatase inhibitors
hereditary breast cancer
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Bernardo Bonanni 的研究动态
Follow Bernardo Bonanni's research updates
留下邮箱，当我们发布与 Bernardo Bonanni（European Institute of Oncology (IEO)）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment